CXCL1 and breast cancer: Herein, we demonstrated that paclitaxel chemotherapy elicited CXCL1‐enriched EV‐Apo from apoptotic breast cancer cells, which promoted the chemoresistance and metastasis of breast cancer by polarizing M2 macrophages through activating PD‐L1 signalling.